Table 3.
Performance metrics of the full model (integrated WELL score and clinicopathologic characteristics) and reference models in the discovery and validation cohorts
Cohort | Model | C-index | iAUC | AIC |
---|---|---|---|---|
Discovery cohort (D1) | TNM stage | 0.651 (0.592–0.710) | 0.634 | 629.2 |
WELL score | 0.622 (0.563–0.681) | 0.618 | 650.2 | |
TNM_WELL | 0.709 (0.646–0.772) | 0.700 | 622.9 | |
Clinicopathologic | 0.723 (0.658–0.788) | 0.715 | 618.9 | |
Full | 0.751 (0.686–0.815) | 0.743 | 614.0 | |
Validation cohort 1 (V1) | TNM stage | 0.586 (0.511–0.661) | 0.590 | 417.4 |
WELL score | 0.589 (0.523–0.655) | 0.609 | 413.7 | |
TNM_WELL | 0.627 (0.548–0.707) | 0.659 | 411.4 | |
Clinicopathologic | 0.596 (0.512–0.680) | 0.593 | 417.9 | |
Full | 0.622 (0.535–0.709) | 0.664 | 413.0 | |
Validation cohort 2 (V2) | TNM stage | 0.632 (0.547–0.717) | 0.634 | 267.2 |
WELL score | 0.587 (0.509–0.664) | 0.587 | 273.5 | |
TNM_WELL | 0.679 (0.592–0.767) | 0.676 | 264.3 | |
Clinicopathologic | 0.650 (0.556–0.744) | 0.648 | 267.0 | |
Full | 0.683 (0.593–0.773) | 0.684 | 264.3 | |
Validation cohort 3 (V3) | TNM stage | 0.565 (0.516–0.613) | 0.552 | 853.4 |
WELL score | 0.527 (0.488–0.565) | 0.543 | 857.3 | |
TNM_WELL | 0.585 (0.531–0.639) | 0.580 | 850.7 | |
Clinicopathologic | 0.586 (0.521–0.651) | 0.575 | 852.5 | |
Full | 0.596 (0.529–0.663) | 0.597 | 850.3 |